| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 113.4× | 27.9× | |
| Price / Book | 17.0× | 4.1× | |
| Price / Sales | 16.1× | 2.9× | |
| Price / Free cash flow | 73.6× | −12.3× | |
| EV / EBITDA | 62.6× | 21.7× | |
| Earnings yield | 0.9% | 2.1% | |
| Free cash flow yield | 1.4% | −3.3% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LENSE:LENSKARTLenskart Solutions Ltd · 🇮🇳 NSE | ₹640.00 | −1.01% | $11.63B | 226.5× | 5.6% | — |
RUNSE:RUBICONRubicon Research Ltd · 🇮🇳 NSE | ₹1,481.80 | −1.78% | $2.52B | 99.0× | 19.1% | — |
CONSE:CORONACorona Remedies Ltd · 🇮🇳 NSE | ₹2,018.90 | +0.75% | $1.32B | 67.6× | 24.8% | — |
SYNSE:SYMBIOTECSymbiotec Pharmalab Limited · 🇮🇳 NSE | ₹1,254.40 | −1.96% | $831.42M | 83.4× | 11.9% | — |
KPNSE:KPLKwality Pharmaceuticals Ltd · 🇮🇳 NSE | ₹3,361.50 | −1.22% | $357.16M | 51.1× | 20.3% | — |
SHNSE:SHUKRAPHARShukra Pharmaceuticals Ltd. · 🇮🇳 NSE | ₹68.66 | −0.32% | $307.35M | 133.1× | 24.5% | — |
FRNSE:FREDUNFredun Pharmaceuticals Ltd. · 🇮🇳 NSE | ₹1,449.00 | −1.94% | $247.31M | 73.6× | 11.7% | — |
SANSE:SAIPARENTSai Parenteral's Ltd · 🇮🇳 NSE | ₹482.95 | −0.89% | $222.59M | 149.9× | 2.9% | — |
BENSE:BETABeta Drugs Ltd · 🇮🇳 NSE | ₹1,732.80 | −2.82% | $198.11M | 46.8× | 16.9% | −2.0% |
VONSE:VOEPLVirtuoso OptoElectronics Ltd · 🇮🇳 NSE | ₹513.60 | +0.51% | $182.06M | 114.8× | 3.6% | — |
